JP2026507878A5 - - Google Patents
Info
- Publication number
- JP2026507878A5 JP2026507878A5 JP2025551865A JP2025551865A JP2026507878A5 JP 2026507878 A5 JP2026507878 A5 JP 2026507878A5 JP 2025551865 A JP2025551865 A JP 2025551865A JP 2025551865 A JP2025551865 A JP 2025551865A JP 2026507878 A5 JP2026507878 A5 JP 2026507878A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- regimen
- cancer
- composition according
- minneride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363489221P | 2023-03-09 | 2023-03-09 | |
| US63/489,221 | 2023-03-09 | ||
| PCT/US2023/015813 WO2024186320A1 (en) | 2023-03-09 | 2023-03-21 | Drug combination for treatment of pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026507878A JP2026507878A (ja) | 2026-03-06 |
| JP2026507878A5 true JP2026507878A5 (enExample) | 2026-03-31 |
Family
ID=92675407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025551865A Pending JP2026507878A (ja) | 2023-03-09 | 2023-03-21 | 膵臓癌の処置のための複合薬 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4676463A1 (enExample) |
| JP (1) | JP2026507878A (enExample) |
| KR (1) | KR20250154513A (enExample) |
| AU (1) | AU2023435819A1 (enExample) |
| WO (1) | WO2024186320A1 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102596977B (zh) | 2009-05-07 | 2016-06-29 | 明尼苏达大学评议会 | 雷公藤内酯前药 |
| US9150600B2 (en) | 2009-05-07 | 2015-10-06 | Regents Of The University Of Minnesota | Triptolide prodrugs |
| US9511046B2 (en) * | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| WO2014167581A2 (en) * | 2013-04-01 | 2014-10-16 | Laurus Labs Private Limited | An improved process for the preparation of triptolide prodrugs |
| WO2015127011A1 (en) * | 2014-02-21 | 2015-08-27 | Institute Of Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | C-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition |
| US10975146B2 (en) * | 2018-06-29 | 2021-04-13 | Cedars-Sinai Medical Center | Interleukin-1 inhibition for combination treatment of pancreatic cancer |
| US11819498B2 (en) * | 2019-12-30 | 2023-11-21 | Unm Rainforest Innovations | Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation |
| WO2021231678A1 (en) * | 2020-05-13 | 2021-11-18 | University Of Massachusetts | Reducing prominin2-mediated resistance to ferroptotic cell death |
-
2023
- 2023-03-21 AU AU2023435819A patent/AU2023435819A1/en active Pending
- 2023-03-21 WO PCT/US2023/015813 patent/WO2024186320A1/en not_active Ceased
- 2023-03-21 EP EP23926583.8A patent/EP4676463A1/en active Pending
- 2023-03-21 JP JP2025551865A patent/JP2026507878A/ja active Pending
- 2023-03-21 KR KR1020257033209A patent/KR20250154513A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023174661A5 (enExample) | ||
| JP4463687B2 (ja) | 腹膜透析法 | |
| JP2022121594A5 (enExample) | ||
| JP2023534009A5 (enExample) | ||
| CN109985237B (zh) | 一种治疗结直肠癌的药物组合物及其应用 | |
| JP2024516795A5 (enExample) | ||
| JP6063550B2 (ja) | 薬物誘発性手足症候群を治療するための組成物および方法 | |
| JP2023115271A5 (enExample) | ||
| JP2023116697A5 (enExample) | ||
| JP2023531675A5 (enExample) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023088996A5 (enExample) | ||
| JP2024016209A5 (enExample) | ||
| JP2025148449A5 (enExample) | ||
| JP2006511538A5 (enExample) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| Seyfer et al. | Toxic lesions of the hand associated with chemotherapy | |
| JP2025060703A5 (enExample) | ||
| JP2024531799A5 (enExample) | ||
| JP2023548303A5 (enExample) | ||
| Meuret et al. | Early stage of fulminant idiopathic pulmonary fibrosis cured by intense combination therapy using cyclophosphamide, vincristine, and prednisone | |
| JP2025505738A5 (enExample) | ||
| CN112826820B (zh) | Nlrp3抑制剂及其应用 | |
| Colleoni et al. | Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factors | |
| JP2023512487A5 (enExample) |